Show Notes
May is Mental Health Awareness Month, and as AI becomes more embedded in our daily lives, one of the biggest questions we face is whether these systems can responsibly support emotional and psychological well-being.
AI chatbots are increasingly being used for emotional support, but recent lawsuits faced by OpenAI and earlier ones targeting character.ai and Google's AI Overviews, as well as clinical reports, and internal research have raised valid concerns about their impact on vulnerable users.
What does it take to build an AI system specifically designed for mental health from the ground up? Is that even possible?
In this LIVE episode of The Neuron Podcast, Corey Noles and Grant Harvey speak with Daniel Reid Cahn, co-founder and CEO of Slingshot AI, about Ash, an AI application purpose-built for therapeutic support. Slingshot has raised $93M from a16z, Radical Ventures, and others to develop a foundation model for psychology trained on structured therapeutic conversations across modalities such as CBT, DBT, and psychodynamic therapy.
We discuss the limitations of general-purpose chatbots in mental health contexts, recent controversies surrounding AI and psychiatric risk, and what differentiates a system designed to provide structured therapeutic engagement compared to one being used in a way it was never intended to be. The conversation also explores a broader question: Can AI meaningfully expand access to high-quality mental health care, and where should clear boundaries remain? Or should we keep our counseling where we always have, on a couch with a box of Kleenex and a hug nearby?
🔗 Try Ash: https://www.talktoash.com/
📌 About The Neuron Podcast The Neuron breaks down the biggest stories in AI for 580,000+ daily readers. Our podcast goes deeper with the leaders, founders, and researchers shaping the future of AI. New episodes every week.
Subscribe to The Neuron newsletter — theneuron.ai
More from The Neuron: AI Explained
Neurosurgeon-scientists Alex Ksendzovsky and Jon Pomeraniec explain how The Biological Computing Company uses living neurons as a research platform for AI. Their team grows roughly 150,000 cells on a 4,096-electrode array, sends in patterns such as handwritten digits, records how the neurons respond, and models useful computational behaviors in software. They say those neuron-inspired techniques are already helping GPU-based video-generation systems run about 5x faster with roughly 80% lower inference cost, while their longer-term work explores robots, world models, and real-time biological compute.
OpenAI just dropped 20+ announcements at DevDay 2026, so... yeah, we have some things to talk about. 😺
Runway co-founder Anastasis Germanidis explains Solaris, an “interface world model” that generates software frame by frame instead of rendering a traditional interface from HTML and CSS.
OpenAI DevDay 2026 is here, and we’re hosting a watch party to watch the keynote LIVE.
Corey and Grant sit down with Mammoth Biosciences co-founder and CEO Dr. Trevor Martin to explain how CRISPR is moving from a laboratory tool toward one-time medicines.